Alto Neuroscience, Inc. ANRO
ANRO
Alto Neuroscience, Inc. CRDF
Cardiff Oncology, Inc. MIST
Milestone Pharmaceuticals Inc. APLT
Applied Therapeutics, Inc. ACHV
Achieve Life Sciences, Inc. ACTU
Actuate Therapeutics Inc ELTX
Elicio Therapeutics, Inc. MLLCF
Molecular Partners AG VTGN
VistaGen Therapeutics, Inc. PYXS
Pyxis Oncology, Inc.
Alto Neuroscience, Inc. CRDF
Cardiff Oncology, Inc. MIST
Milestone Pharmaceuticals Inc. APLT
Applied Therapeutics, Inc. ACHV
Achieve Life Sciences, Inc. ACTU
Actuate Therapeutics Inc ELTX
Elicio Therapeutics, Inc. MLLCF
Molecular Partners AG VTGN
VistaGen Therapeutics, Inc. PYXS
Pyxis Oncology, Inc.
Performance
| Periode | ANRO | CRDF | MIST | APLT | ACHV | ACTU | ELTX | MLLCF | VTGN | PYXS |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 164.79 % | -10.53 % | 158.01 % | 153.04 % | 41.28 % | 1.70 % | 111.60 % | -17.06 % | 90.09 % | 285.94 % |
| YTD | 28.77 % | -48.12 % | -8.29 % | 4.69 % | -16.53 % | -2.14 % | 105.84 % | -14.84 % | 21.39 % | 118.93 % |
| 1Y | -59.45 % | -15.97 % | 34.46 % | -89.42 % | -38.28 % | -1.79 % | 129.50 % | -22.22 % | 33.44 % | 15.99 % |
| 3Y | -72.75 % | 35.58 % | -77.05 % | 74.13 % | 5.12 % | -9.52 % | 79.63 % | -44.36 % | 3.33 % | 140.26 % |
| 5Y | -72.75 % | -86.63 % | -73.36 % | -95.93 % | -68.51 % | -9.52 % | 79.63 % | -80.56 % | -82.09 % | -71.97 % |
| 10Y | -72.75 % | -99.46 % | -87.05 % | -90.00 % | -99.93 % | -9.52 % | 79.63 % | -84.53 % | -98.30 % | -71.97 % |
| Depuis le début | -72.75 % | -99.86 % | -87.05 % | -90.00 % | -100.00 % | -9.52 % | 79.63 % | -84.53 % | -99.73 % | -71.97 % |